Half the time. Half the cost.
Our ambition is to cut the time and cost of taking a new lifesaving medication to market in half by 2030.
Come Work With UsA future where lifesaving medicines arrive sooner.
Builders, scientists and creatives.
- Reza FarahaniCo-Founder, CEO


- Shreyas BeckerCo-Founder, COO


- Andrew GriloCFO


- Hannes Bretschneider, PhDChief AI Officer


- Anna ErshovaHead of Product


- Matt CruzHead of Engineering


- Zack HollandHead of Marketing


- Lee BowmanHead of Operations


- Nikta KanukaSenior Product Manager


- Derrek EvansEnterprise Account Executive


- Jim HazlewoodFront End Developer


- Thomas QinData Scientist


- Alireza DarbehaniAI Engineer


- Carlos BolivarSenior Deployment Strategist


- Jay ModiDeployment Strategist


- Joeri Van Wijngaarden, PhDSenior Deployment Strategist


- Tom GribilasData Science Intern


- Alyse Gonthier, PhDHead of Content


- Ram AnanthML Scientist


- Liam OenGrant & Ops Support


- Tonny HuangDeployment Strategist


- Saba CharmiData Scientist


- Ali Vahid-YeganehSenior Product Designer


- Ruk SeneviratneMarketing Ops


- Alireza Keshavarzian, PhDSenior Data Scientist


- Arshad Azwad, PhDEnterprise Account Executive


- Allison MurdockData Scientist


- Liz VillamizarExecutive Assistant to COO


- Alix FadenEvents & Community


- Emma Ramos SochaExecutive Assistant to CEO


- Micol AltomareProduct Manager


- Oliver DanielFull-Stack Engineer


- Kiana YazdiSoftware Engineer Intern


- Emily SinProduct Designer


- Dan Van DammeEnterprise Account Executive


- Arun JosephFull-Stack Engineer


- CareersJoin the Team
San Francisco, Toronto and New York City.
- San Francisco
- Toronto
- New York City


Built with the people who make medicine.
More than a hundred scientists and engineers from across pharma, from companies such as Pfizer, Sanofi and Lilly, are helping shape Katalyze, and the future of their own industry with it. They know what it takes to get a medicine to the people who need it. If you do too, come build with us.
Erik PrieditisCOO at Sentrex Health Solutions
Nicole K. Paulk, PhDFounder and CEO of Siren Biotechnology
Mike TomascoChief Information Officer at Fujifilm
Chris CalabrettaFormer executive at J&J
Shachi SharmaChief Quality Officer at LabConnect
Michael BurtonFormer Senior Director at Veeva Systems

Most AI in this category is a thin copilot bolted onto legacy tools. Katalyze went the other way and built real infrastructure. By putting a GxP-native context layer underneath autonomous agents, they let AI reason across the messy, fragmented data of pharma manufacturing and actually do the work: solving deviations faster, improving yield, running critical workflows at a fraction of the cost. That's the unlock the industry has been waiting for, and Reza's team is the one delivering it.
Backed by Bonfire Ventures, Inovia Capital, Ripple Ventures and Alumni Ventures, with angel investors including Gokul Rajaram and Farzad Soleimani.
Speak with Reza Regarding InvestmentFor the science. For the people it serves.
More than 10 million doses have made their way to patients around the globe through Katalyze, and counting.






